8chan/8kun QResearch Posts (1)
#8431147 at 2020-03-16 01:10:38 (UTC+1)
Q Research General #10794: This Bread Was Baked Gloved And Masked Edition
WASHINGTON (AP) - A clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday, according to a government official. (An hour ago)
https://apnews.com/8089a3d0ec8f9fde971bddd7b3aa2ba1
Will Moderna Make a Fortune Off Its Coronavirus Vaccine? 3/11/2020
https://www.nasdaq.com/articles/will-moderna-make-a-fortune-off-its-coronavirus-vaccine-2020-03-11
https://www.modernatx.com/about-us/executive-committee-leadership
CEO
Stéphane Bancel joined Moderna joined Moderna in the summer of 2011 when it was a one employee company. He has assembled a world-class team and raised nearly $2 billion between equity financing and upfront from licensing collaborations.
CO-FOUNDER & BOARD CHAIRMAN
Noubar Afeyan, Ph.D., is co-founder and chairman of Moderna, and CEO of Flagship Pioneering, a leading early stage venture capital firm. He also leads the firm's VentureLabs unit that invents and launches transformative startups.
Board of Directors:
Noubar Afeyan, Ph.D., Co-founder and Chairman, Moderna; CEO, Flagship Pioneering
Stéphane Bancel, Chief Executive Officer, Moderna
Stephen Berenson, Managing Partner, Flagship Pioneering
Robert Langer, Sc.D., Academic Co-Founder, Moderna; David H. Koch Institute Professor, MIT
Elizabeth Nabel, M.D., President, Brigham Health
François Nader, M.D., Former President, CEO and Executive Director, NPS Pharmaceuticals
Israel Ruiz, Audit Committee Chair, Moderna; Executive Vice President and Treasurer, Massachusetts Institute of Technology
Paul Sagan, Managing Director, General Catalyst
Moncef Slaoui, Ph.D., Former Chairman of Global Vaccines, GlaxoSmithKline PLC (GSK)